wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26798352-50865B6E-2F30-4548-97C9-B41F1A71C0DE
Q26798352-50865B6E-2F30-4548-97C9-B41F1A71C0DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798352-50865B6E-2F30-4548-97C9-B41F1A71C0DE
PARP inhibitors in the management of breast cancer: current data and future prospects
P2860
Q26798352-50865B6E-2F30-4548-97C9-B41F1A71C0DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26798352-50865B6E-2F30-4548-97C9-B41F1A71C0DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5832c5ef5af6485cc82c43a718852db52c073c70
P2860
Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours.